172@29@16@55!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_COMPINFO&priceinter=1&frommc=1!~!|commonstore|commonfiles|moneycontrol_header.php
Moneycontrol
SENSEX NIFTY
you are here:

Bharat Immunologicals and Biologicals Corporation Ltd.

BSE: 524663 | NSE: | Series: NA | ISIN: INE994B01014 | SECTOR: Pharmaceuticals

BSE Live

Aug 03, 16:00
33.20 0.61 (1.87%)
Volume
AVERAGE VOLUME
5-Day
233,462
10-Day
315,270
30-Day
150,959
798,174
  • Prev. Close

    32.59

  • Open Price

    31.95

  • Bid Price (Qty.)

    33.20 (196770)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Dec 27, 11:22
NT* 0.00 (0.00%)
Volume
No Data Available
0
  • Prev. Close

    -

  • Open Price

    -

  • Bid Price (Qty.)

    - (0)

  • Offer Price (Qty.)

    - (0)

Bharat Immunologicals and Biologicals Corporation is not listed on NSE
Company History - Bharat Immunologicals and Biologicals Corporation
Bharat Immunological and Biologicals corporation Limited incorporated
 on 10 March, 1989 as a Public Limited Company under the Companies
 Act, rated on 10 March, 1989 as a Public Limited Company under the
 Companies Act, 1956 and obtained the certificate of commencement of
 business on 20th March, 1989 from the Registrar of companies, Kanpur,
 Uttar Pradesh. The Registered office of the Company is localted at
 395, Civil Lines, Bulandshahr 203001 Uttar Pradesh. The company is
 setting up a project at village chola, District Bulandharh, Uttar
 Pradesh for the manufacture of 100 million doses of Oral Polio
 Vaccine per annum and also undertake R&D in the area of
 immunologicals.
 
 The Company has been promoted by Government of India, Ministry of
 Science and Technology, Department of Biotechnology in the Public
 sector.
 
 1989
 
 -BIBCOL was established by Department of Biotechnology, Ministry of
 Science & Technology, Govt.of India as a Central Public Sector Unit
 and incorporated under the Companys Act 1956. 
 
 1996
 
 -The company started formulating OPV from bulk.
 
 1999
 
 -The company acquired WHO-GMP certification
 
 2000 
 
 -BIBCOL bagged an order from UNICEF as well as from Ministry of
 Health and Family Welfare, Govt.of India for a total of 170 million
 doses. 
 
 2001
 
 -The company bagged another larger order of 270 million doses from
 UNICEF as well as from the Ministry of Health & Family Welfare,
 Govt.of India. 
 
 2005
 
 -For the first time, the company has signed a MoU with DBT for the
 fiscal year 
 
 2006
 
 -The company has secured a place among the Top 20 Bio tech companies
 in the country through its commendable performance
 
 2007
 
 -Bharat Immunologicals & Biologicals Corporation Ltd  has appointed
 Sh. N S Samant, Joint Secretary, Department of Biotechnology as
 Director of the Company in place of Sh. U N Behera, with effect from
 January 19, 2007.
 
 -Appointment of Shri. S Subbiah, who was appointed as Managing
 Director on the Board of Directors.
 
 2011
 
 -The Company appointed Ms. Sheila Sangwan, Sh. Sreeshan Raghwan and
 Dr. Y. K. Gupta, as Directors of the Company.
 
 2013
 
 - Again BIBCOL bagged full order of MOHFW for supply of Oral Polio
 Vaccine for national immunization programme